Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.7249
+0.00110.15%
Post-market: 0.74420.0193+2.66%19:53 EDT
Volume:120.37K
Turnover:88.12K
Market Cap:54.62M
PE:-1.11
High:0.7514
Open:0.7300
Low:0.7200
Close:0.7238
Loading ...

Cue Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Cue Biopharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $421.00K Miss $1.27M Estimate

Benzinga
·
13 May

Cue Biopharma Inc. Reports Q1 2025 Results: Revenue Falls to $0.4M, Net Loss at $12.3M, EPS at $(0.17)

Reuters
·
13 May

Cue Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
09 May

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire
·
05 May

Cue Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
05 May

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Zacks
·
01 May

BRIEF-Cue Biopharma Prices Common Stock And Warrants At $0.79 Per Share; Pre-Funded Warrants At $0.789

Reuters
·
15 Apr

Cue Biopharma Inc - Common Stock and Warrants Sold at $0.79, Pre-Funded Warrants at $0.789

THOMSON REUTERS
·
15 Apr

Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering

THOMSON REUTERS
·
15 Apr

BRIEF-Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments

Reuters
·
15 Apr

Cue Biopharma Starts Underwritten Equity Offering

MT Newswires Live
·
15 Apr

Cue Biopharma announces common stock, warrant offering, no amount given

TIPRANKS
·
15 Apr

Cue Biopharma receives $12M upfront in CUE-501 license pact

TIPRANKS
·
15 Apr

Cue Biopharma Announces Proposed Public Offering

THOMSON REUTERS
·
15 Apr

Cue Biopharma Announces Proposed Public Offering

GlobeNewswire
·
15 Apr

Boehringer Ingelheim and Cue Biopharma Partner to Develop Treatment for Autoimmune and Inflammatory Diseases

THOMSON REUTERS
·
15 Apr

Cue Biopharma Inc: Co Is Also Eligible to Earn up to About $345 Mln in Milestone-Based Payments

THOMSON REUTERS
·
15 Apr

Cue Biopharma to Host Business Update Call and Webcast

GlobeNewswire
·
15 Apr